活检设备市场－全球产业规模、份额、趋势、机会和预测，按产品类型、疾病类型、解剖结构、引导技术、地区和竞争细分，2020 年至 2030 年

2024 年全球切片设备市场价值为 61.7 亿美元，预计到 2030 年将达到 88.4 亿美元，预测期内复合年增长率为 6.18%。该市场是医疗保健行业的一个重要领域，其发展受到癌症发病率不断上升和对精确诊断方法的需求的推动。活检设备透过收集组织样本进行分析，对于早期识别疾病（尤其是癌症）至关重要。技术创新、人口老化以及对影像导引和液体活检等微创手术的日益青睐进一步推动了这一需求。机器人和人工智慧的进步也提高了诊断的准确性和程序效率。

关键市场驱动因素

癌症发生率上升

主要市场挑战

切片费用高昂

主要市场趋势

微创技术的发展

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：全球切片设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（组织切片、液体切片）
  • 依疾病类型（癌症、感染、自体免疫疾病、非癌症适应症、其他）
  • 依解剖学分类（乳房、肺、骨、肝、子宫/子宫颈/卵巢、腹部、前列腺、心臟、皮肤、其他）
  • 依引导技术（X 光引导活检、超音波引导活检、MRI 引导活检、CT 引导活检）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 依产品类型
  • 依疾病类型
  • 按解剖学
  • 透过引导技术
  • 按地区

第五章：亚太地区切片设备市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型
  • 依疾病类型
  • 按解剖学
  • 透过引导技术
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 澳洲
  • 日本
  • 韩国

第六章：欧洲切片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 西班牙
  • 义大利
  • 英国

第七章：北美切片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第八章：南美洲切片设备市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第九章：中东和非洲活检设备市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第十章：市场动态

• 驱动程式
• 挑战

第 11 章：市场趋势与发展

• 最新动态
• 产品发布
• 併购

第 12 章：全球切片设备市场：SWOT 分析

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE HealthCare
• Inrad, Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Biopsy Devices Market was valued at USD 6.17 billion in 2024 and is anticipated to reach USD 8.84 billion by 2030, registering a CAGR of 6.18% during the forecast period. This market is a vital segment of the healthcare industry, driven by the growing incidence of cancer and the need for precise diagnostic methods. Biopsy devices are essential in identifying diseases at early stages, particularly cancer, by collecting tissue samples for analysis. The demand is further fueled by technological innovations, an aging population, and the increasing preference for minimally invasive procedures like image-guided and liquid biopsies. Advancements in robotics and AI are also enhancing diagnostic accuracy and procedural efficiency.

Key Market Drivers

Rising Cancer Prevalence

The escalating global incidence of cancer significantly propels the demand for biopsy devices. As cancer becomes more widespread, the need for accurate diagnostic methods grows more urgent. Biopsy procedures are critical in confirming cancer diagnoses, determining types and stages, and guiding effective treatment plans. According to the Union for International Cancer Control (UICC), the number of new cancer cases is projected to exceed 35 million by 2050, marking a 77% increase from 2022. This alarming rise underscores the importance of biopsy tools in healthcare systems, as early and reliable diagnosis is central to improving patient outcomes and expanding access to appropriate therapies.

Key Market Challenges

High Cost of Biopsy Procedures

A significant challenge for the global biopsy devices market is the high cost associated with biopsy procedures. These costs include not only the price of specialized equipment but also expenses related to diagnostics, professional services, and post-procedure care. For patients, especially those with limited financial means or inadequate insurance coverage, out-of-pocket expenses can deter timely diagnosis. Even for healthcare providers, the acquisition and maintenance of advanced biopsy equipment, workforce training, and regulatory compliance impose substantial financial burdens. These economic constraints limit accessibility and slow adoption, particularly in developing regions, posing a barrier to market expansion.

Key Market Trends

Growth of Minimally Invasive Techniques

The increasing adoption of minimally invasive biopsy techniques is a transformative trend in the global biopsy devices market. Unlike traditional surgical biopsies, these methods-such as fine-needle aspiration, core needle biopsies, and image-guided procedures-offer less invasive alternatives with reduced discomfort and faster recovery. These patient-friendly approaches not only improve diagnostic efficiency but also increase the appeal of biopsy procedures, driving demand. Minimally invasive methods enable sampling from hard-to-reach areas and are associated with lower complication rates. Their growing acceptance among both patients and providers is accelerating market growth and reshaping diagnostic practices across healthcare systems.

Key Market Players

• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE HealthCare
• Inrad, Inc

Report Scope:

In this report, the Global Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopsy Devices Market, By Product Type:

• Tissue Biopsy
• Liquid Biopsy

Biopsy Devices Market, By Disease Type:

• Cancer
• Infections
• Autoimmune Disorders
• Non-Cancerous Indications
• Others

Biopsy Devices Market, By Anatomy:

• Breast
• Lung
• Bone
• Liver
• Uterus/Cervix/Ovary
• Abdomen
• Prostate
• Cardiac
• Skin
• Others

Biopsy Devices Market, By Guidance Technique:

• X-Ray-Guided Biopsy
• Ultrasound-Guided Biopsy
• MRI-Guided Biopsy
• CT-Guided Biopsy

Biopsy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biopsy Devices Market.

Available Customizations:

Global Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Biopsy Devices Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type (Tissue Biopsy, Liquid Biopsy)
  • 4.2.2. By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others)
  • 4.2.3. By Anatomy (Breast, Lung, Bone, Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, Others)
  • 4.2.4. By Guidance Technique (X-Ray-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product Type
  • 4.3.2. By Disease Type
  • 4.3.3. By Anatomy
  • 4.3.4. By Guidance Technique
  • 4.3.5. By Region

5. Asia Pacific Biopsy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
  • 5.2.2. By Disease Type
  • 5.2.3. By Anatomy
  • 5.2.4. By Guidance Technique
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Biopsy Devices Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
      • 5.3.1.2.2. By Disease Type
      • 5.3.1.2.3. By Anatomy
      • 5.3.1.2.4. By Guidance Technique
  • 5.3.2. India Biopsy Devices Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product Type
      • 5.3.2.2.2. By Disease Type
      • 5.3.2.2.3. By Anatomy
      • 5.3.2.2.4. By Guidance Technique
  • 5.3.3. Australia Biopsy Devices Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product Type
      • 5.3.3.2.2. By Disease Type
      • 5.3.3.2.3. By Anatomy
      • 5.3.3.2.4. By Guidance Technique
  • 5.3.4. Japan Biopsy Devices Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product Type
      • 5.3.4.2.2. By Disease Type
      • 5.3.4.2.3. By Anatomy
      • 5.3.4.2.4. By Guidance Technique
  • 5.3.5. South Korea Biopsy Devices Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product Type
      • 5.3.5.2.2. By Disease Type
      • 5.3.5.2.3. By Anatomy
      • 5.3.5.2.4. By Guidance Technique

6. Europe Biopsy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Type
  • 6.2.3. By Anatomy
  • 6.2.4. By Guidance Technique
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Biopsy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Type
      • 6.3.1.2.3. By Anatomy
      • 6.3.1.2.4. By Guidance Technique
  • 6.3.2. Germany Biopsy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Type
      • 6.3.2.2.3. By Anatomy
      • 6.3.2.2.4. By Guidance Technique
  • 6.3.3. Spain Biopsy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Type
      • 6.3.3.2.3. By Anatomy
      • 6.3.3.2.4. By Guidance Technique
  • 6.3.4. Italy Biopsy Devices Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Disease Type
      • 6.3.4.2.3. By Anatomy
      • 6.3.4.2.4. By Guidance Technique
  • 6.3.5. United Kingdom Biopsy Devices Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Disease Type
      • 6.3.5.2.3. By Anatomy
      • 6.3.5.2.4. By Guidance Technique

7. North America Biopsy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Type
  • 7.2.3. By Guidance Technique
  • 7.2.4. By Anatomy
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Biopsy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Type
      • 7.3.1.2.3. By Anatomy
      • 7.3.1.2.4. By Guidance Technique
  • 7.3.2. Mexico Biopsy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Type
      • 7.3.2.2.3. By Anatomy
      • 7.3.2.2.4. By Guidance Technique
  • 7.3.3. Canada Biopsy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Type
      • 7.3.3.2.3. By Anatomy
      • 7.3.3.2.4. By Guidance Technique

8. South America Biopsy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Type
  • 8.2.3. By Guidance Technique
  • 8.2.4. By Anatomy
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Biopsy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Type
      • 8.3.1.2.3. By Anatomy
      • 8.3.1.2.4. By Guidance Technique
  • 8.3.2. Argentina Biopsy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Type
      • 8.3.2.2.3. By Anatomy
      • 8.3.2.2.4. By Guidance Technique
  • 8.3.3. Colombia Biopsy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Type
      • 8.3.3.2.3. By Anatomy
      • 8.3.3.2.4. By Guidance Technique

9. Middle East and Africa Biopsy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Type
  • 9.2.3. By Anatomy
  • 9.2.4. By Guidance Technique
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Biopsy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Type
      • 9.3.1.2.3. By Anatomy
      • 9.3.1.2.4. By Guidance Technique
  • 9.3.2. Saudi Arabia Biopsy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Type
      • 9.3.2.2.3. By Anatomy
      • 9.3.2.2.4. By Guidance Technique
  • 9.3.3. UAE Biopsy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Type
      • 9.3.3.2.3. By Anatomy
      • 9.3.3.2.4. By Guidance Technique

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Biopsy Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Argon Medical Devices, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. B. Braun SE
• 14.3. Becton, Dickinson and Company
• 14.4. Boston Scientific Corporation
• 14.5. Cardinal Health, Inc.
• 14.6. Cook Medical Inc.
• 14.7. Conmed Corporation
• 14.8. FUJIFILM Holdings Corporation
• 14.9. GE HealthCare
• 14.10. Inrad, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer